INTANGIBLE ASSETS, NET |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 31, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Intangible Asset, Goodwill and Other [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| INTANGIBLE ASSETS, NET | NOTE 5: INTANGIBLE ASSETS, NET
Acquired intangible assets with finite lives consisted of the following as of July 31, 2026 and 2025:
The patents relate to intellectual property held by BriaPro and are amortized over 20 years.
Amortization expenses for the years ended July 31, 2026 and 2025, were $15,271 and $15,271, respectively.
The estimated future amortization expense of intangible assets as of July 31, 2026 is as follows:
BriaCell Therapeutics Corp Notes to the Consolidated Financial Statements For the Years Ended July 31, 2026 and 2025 (Expressed in US Dollars, unless otherwise indicated)
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||